As the vascular community continues to unpack the key learnings from two of the biggest trials to date in chronic limb threatening ischemia—BEST-CLI and BASIL-2—attendees of the 2023 Vascular Annual Meeting (VAM) in National Harbor, Maryland (June 14–17) told Vascular Specialist how they see the two landmark trials shaping practice in years to come.
